Daniel Aran Solomon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance Abuse, Intravenous | 4 | 2023 | 529 | 1.460 |
Why?
|
Epidemics | 2 | 2023 | 512 | 1.120 |
Why?
|
Influenza Vaccines | 2 | 2020 | 767 | 0.850 |
Why?
|
HIV Infections | 7 | 2024 | 17349 | 0.760 |
Why?
|
Opioid-Related Disorders | 4 | 2023 | 2164 | 0.660 |
Why?
|
Influenza, Human | 2 | 2020 | 1521 | 0.650 |
Why?
|
Anti-HIV Agents | 4 | 2024 | 4526 | 0.550 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1376 | 0.540 |
Why?
|
Tracheomalacia | 2 | 2012 | 63 | 0.480 |
Why?
|
Seasons | 1 | 2020 | 1517 | 0.470 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 787 | 0.440 |
Why?
|
Hepatitis, Alcoholic | 1 | 2015 | 109 | 0.430 |
Why?
|
Drug Monitoring | 1 | 2019 | 961 | 0.420 |
Why?
|
Disease Management | 2 | 2024 | 2508 | 0.420 |
Why?
|
Physician's Role | 2 | 2020 | 916 | 0.410 |
Why?
|
Confidentiality | 1 | 2015 | 607 | 0.360 |
Why?
|
Bacterial Infections | 1 | 2019 | 1390 | 0.350 |
Why?
|
Bacteriophages | 2 | 2023 | 378 | 0.320 |
Why?
|
Students, Medical | 1 | 2022 | 1938 | 0.320 |
Why?
|
Pandemics | 3 | 2022 | 8663 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3094 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3216 | 0.260 |
Why?
|
Endocarditis | 2 | 2020 | 349 | 0.260 |
Why?
|
Anti-Bacterial Agents | 4 | 2023 | 7405 | 0.250 |
Why?
|
Patients | 1 | 2010 | 906 | 0.230 |
Why?
|
Mycobacterium chelonae | 1 | 2022 | 12 | 0.200 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3238 | 0.190 |
Why?
|
Skin Diseases, Bacterial | 1 | 2022 | 67 | 0.190 |
Why?
|
HIV-1 | 2 | 2017 | 6851 | 0.190 |
Why?
|
Drug Substitution | 1 | 2024 | 291 | 0.190 |
Why?
|
Mycobacterium | 1 | 2023 | 251 | 0.190 |
Why?
|
Tissue Donors | 1 | 2010 | 2334 | 0.180 |
Why?
|
Bone Diseases, Infectious | 1 | 2020 | 16 | 0.180 |
Why?
|
Analgesics, Opioid | 4 | 2023 | 3808 | 0.160 |
Why?
|
Microbiology | 1 | 2018 | 70 | 0.150 |
Why?
|
Data Display | 1 | 2018 | 175 | 0.150 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2018 | 108 | 0.140 |
Why?
|
Decision Making | 1 | 2010 | 3925 | 0.140 |
Why?
|
Treatment Refusal | 1 | 2020 | 429 | 0.130 |
Why?
|
Asthma | 2 | 2012 | 6229 | 0.130 |
Why?
|
Endocarditis, Bacterial | 1 | 2020 | 436 | 0.130 |
Why?
|
Prevalence | 2 | 2023 | 15717 | 0.130 |
Why?
|
Pharmaceutical Preparations | 2 | 2023 | 1086 | 0.130 |
Why?
|
Humans | 23 | 2024 | 761098 | 0.130 |
Why?
|
Pregnant Women | 1 | 2020 | 567 | 0.130 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2024 | 1895 | 0.130 |
Why?
|
Buprenorphine | 2 | 2020 | 656 | 0.130 |
Why?
|
Opiate Substitution Treatment | 1 | 2020 | 444 | 0.130 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4240 | 0.120 |
Why?
|
HIV Protease Inhibitors | 1 | 2017 | 432 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.120 |
Why?
|
Kidney | 1 | 2010 | 7034 | 0.120 |
Why?
|
Internship and Residency | 1 | 2015 | 5879 | 0.120 |
Why?
|
Pilot Projects | 2 | 2022 | 8639 | 0.120 |
Why?
|
Bacteremia | 1 | 2020 | 978 | 0.110 |
Why?
|
Cystic Fibrosis | 1 | 2023 | 1283 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12975 | 0.100 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2757 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2545 | 0.100 |
Why?
|
User-Computer Interface | 1 | 2018 | 1395 | 0.100 |
Why?
|
Cough | 2 | 2012 | 594 | 0.090 |
Why?
|
United States | 3 | 2023 | 72337 | 0.080 |
Why?
|
Boston | 1 | 2022 | 9324 | 0.080 |
Why?
|
Patient Compliance | 1 | 2020 | 2687 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2020 | 2769 | 0.080 |
Why?
|
Curriculum | 1 | 2022 | 3739 | 0.080 |
Why?
|
Vaccination | 1 | 2020 | 3368 | 0.080 |
Why?
|
Respiratory Sounds | 1 | 2012 | 702 | 0.070 |
Why?
|
Dyspnea | 2 | 2012 | 1347 | 0.070 |
Why?
|
Administration, Oral | 1 | 2015 | 4014 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4849 | 0.070 |
Why?
|
Forced Expiratory Volume | 1 | 2012 | 1813 | 0.070 |
Why?
|
Patient Discharge | 1 | 2020 | 3441 | 0.070 |
Why?
|
Specialties, Surgical | 1 | 2010 | 389 | 0.060 |
Why?
|
Waiting Lists | 1 | 2010 | 765 | 0.060 |
Why?
|
Glucocorticoids | 2 | 2012 | 2160 | 0.060 |
Why?
|
Adult | 7 | 2020 | 221083 | 0.050 |
Why?
|
Compassionate Use Trials | 1 | 2023 | 50 | 0.050 |
Why?
|
Tissue and Organ Procurement | 1 | 2010 | 962 | 0.050 |
Why?
|
Clarithromycin | 1 | 2022 | 86 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3405 | 0.050 |
Why?
|
Hospitalization | 1 | 2019 | 10712 | 0.040 |
Why?
|
Male | 6 | 2020 | 360675 | 0.040 |
Why?
|
Methadone | 1 | 2020 | 321 | 0.040 |
Why?
|
Naltrexone | 1 | 2020 | 317 | 0.040 |
Why?
|
Female | 7 | 2020 | 392458 | 0.030 |
Why?
|
Injections | 1 | 2020 | 832 | 0.030 |
Why?
|
Systems Integration | 1 | 2018 | 428 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 74219 | 0.030 |
Why?
|
Bilirubin | 1 | 2017 | 435 | 0.030 |
Why?
|
Narcotic Antagonists | 1 | 2020 | 585 | 0.030 |
Why?
|
Age Factors | 1 | 2010 | 18385 | 0.030 |
Why?
|
Obesity | 2 | 2012 | 12937 | 0.030 |
Why?
|
Child | 1 | 2020 | 80134 | 0.020 |
Why?
|
Pulmonary Atelectasis | 1 | 2012 | 143 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2018 | 873 | 0.020 |
Why?
|
Prognosis | 1 | 2010 | 29672 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5249 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39121 | 0.020 |
Why?
|
Middle Aged | 4 | 2020 | 220835 | 0.020 |
Why?
|
Viral Load | 1 | 2017 | 3328 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9648 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2020 | 80673 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3114 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3268 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4421 | 0.020 |
Why?
|
Young Adult | 1 | 2010 | 59199 | 0.010 |
Why?
|
Radiography | 1 | 2012 | 6975 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2018 | 4813 | 0.010 |
Why?
|
Aged | 1 | 2010 | 169266 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26068 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64670 | 0.010 |
Why?
|
Lung | 1 | 2012 | 9979 | 0.010 |
Why?
|